This company is toxic,
Going Concern
The ability of the Company to continue as a going concern is dependent on the successful execution of Management's
plans, which include sales of its products, further implementation of its business plan and continuing to raise funds
through debt or equity financings. The Company will likely need to rely upon debt or equity financing in order to ensure
the continuing existence of the business.
The accompanying unaudited financial statements have been prepared on a going concern basis, which contemplates
the realization of assets and the satisfaction of liabilities in the normal course of business.
During October 2014, the Company issued a total of 132,853,956 restricted common shares to members of OneBode
Holdings LLC and OneBode Ventures LLC comprised of 51,263,676 shares for the final payment of their membership
interests valued at $647,297 and 81,590,270 shares to pay down $481,780 of debt assumed in the acquisition.
During the quarter ended March 31, 2014, the Company issued 370,895,682 common shares to retire $203,993 of
debenture debt and accrued interest to various debenture holders.
During the quarter ended June 30, 2014, the Company issued 1,365,671 common shares for past services rendered
by its past Chief Operating Officer, 2,000,000 shares to its current President as part of his employment agreement and
17,534,624 common shares for service rendered during 2013 by a director. The Company also issued 22,901,818
common shares to a debenture holder in payment of $11,000 of principal and $1,596 of accrued interest.
During the quarter ended September 30, 2014, the Company issued 91,561,818 common shares to retire $50,359 of
principal and accrued interest on two debentures (see note 5 for details). It also issued 31,361,763 common shares to
officers for past services rendered valued at $90,750 and 7,784,070 common shares to consultants valued at $23,000.
At September 30, 2014, the Company had 4,750,000,000 authorized common shares and 4,026,082,442 common
shares issued and outstanding. See note 4 for details.
